{"ticker": {"uuid": "dc9f58e5-33ff-4bfe-bb0a-31717738b1de", "symbol": "130A", "name": "VERITAS IN SILICO INC", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Takeda Ends Veritas In Silico Pact As mRNA Focus And Valuation Watched", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNb2E5Yy1zQTVNZlRGT1ZVZ1p4UWk0T2FrSE8wM09NT2lnVkNLSFJnUUd3N0puOGJ3OExJOUxHX3BhenhGejVwUXI3UzRfbWl1U0phR0g1N1o1MmloMC1FOGdSWndzSGJXX3N5bzlyV2dSNEMzZ3NGbkMxcEg2bU92WmZJVklpclY1T2VJWTd5SWhNbkw3OV8wYnI2cDN0bGNidkE?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda continues to prune partnerships, cuts ties with mRNA-targeting Veritas In Silico", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQT1cyR3pfU2NEVUs1bFBMUElKZThxcFhYdzN3UDZoQWtHMUxDb3huclpTV0IybFVDMllhQnB5TnJSNHFGRkpzbmxOMTRSMjZHbEE2T3Eya3hDdmNIOUhmSEF2T0lfNXdRNlFYV0Z4a0VDZzBXOHlCSGtMZnFjMGRVZ016amQ3dHRGeGxxZUVZakRpWG9EU01uODhVN1hWUmJXd09ZS21EUkxQQW0taUNMZ1RJa0VCdjJTbGxWdg?oc=5", "source_name": "BioSpace", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veritas In Silico Launches First In-House Nucleic Acid Drug Project", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPQmc3SXVIZmg2Q0dfOEtBaThzQ0pPMHFkRVpHN0UzWG16dnpodTVzNzlpOXdFYmt6ZjhvRTJ2ZHIxOWZhckYtWjdZZm9qdndYeWJic0hGU3NqaUszNDBNOWN6R3FqZE1rVUlxREdfTDFIdWpqTEpMYlRCRXR4NEtkWV94b1N4WkliaWNpUHB1cU1lbDdvV25ZSWkxTzZVeU1TZHdrNEtrLUxMUmJQOU9ZTktTVmlIZlR6b2Vr?oc=5", "source_name": "TipRanks", "published_at": "2025-06-16T07:00:00+00:00", "published_display": "16 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Takeda Ends Veritas In Silico Pact As mRNA Focus And Valuation Watched", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNb2E5Yy1zQTVNZlRGT1ZVZ1p4UWk0T2FrSE8wM09NT2lnVkNLSFJnUUd3N0puOGJ3OExJOUxHX3BhenhGejVwUXI3UzRfbWl1U0phR0g1N1o1MmloMC1FOGdSWndzSGJXX3N5bzlyV2dSNEMzZ3NGbkMxcEg2bU92WmZJVklpclY1T2VJWTd5SWhNbkw3OV8wYnI2cDN0bGNidkE?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Takeda continues to prune partnerships, cuts ties with mRNA-targeting Veritas In Silico", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQT1cyR3pfU2NEVUs1bFBMUElKZThxcFhYdzN3UDZoQWtHMUxDb3huclpTV0IybFVDMllhQnB5TnJSNHFGRkpzbmxOMTRSMjZHbEE2T3Eya3hDdmNIOUhmSEF2T0lfNXdRNlFYV0Z4a0VDZzBXOHlCSGtMZnFjMGRVZ016amQ3dHRGeGxxZUVZakRpWG9EU01uODhVN1hWUmJXd09ZS21EUkxQQW0taUNMZ1RJa0VCdjJTbGxWdg?oc=5", "source_name": "BioSpace", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veritas In Silico Launches First In-House Nucleic Acid Drug Project", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPQmc3SXVIZmg2Q0dfOEtBaThzQ0pPMHFkRVpHN0UzWG16dnpodTVzNzlpOXdFYmt6ZjhvRTJ2ZHIxOWZhckYtWjdZZm9qdndYeWJic0hGU3NqaUszNDBNOWN6R3FqZE1rVUlxREdfTDFIdWpqTEpMYlRCRXR4NEtkWV94b1N4WkliaWNpUHB1cU1lbDdvV25ZSWkxTzZVeU1TZHdrNEtrLUxMUmJQOU9ZTktTVmlIZlR6b2Vr?oc=5", "source_name": "TipRanks", "published_at": "2025-06-16T07:00:00+00:00", "published_display": "16 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 2, "score": 45, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 437.0, "latest_week": "2026-07-10", "one_week_move": 1.4, "four_week_move": 1.2, "twelve_week_move": -11.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.152739, "market_dynamics_buy_signal": false, "relative_strength": -39.804358, "fair_value_gap": -48.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.7747, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.4% over one week, +1.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 1}, {"label": "BioSpace", "count": 1}, {"label": "TipRanks", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "45/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.4% over one week, +1.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Takeda Ends Veritas In Silico Pact As mRNA Focus And Valuation Watched"}], "updated_at": "2026-07-17T16:53:11.479301+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}